With the threat of a second nationwide lockdown, an AI employee health data management tool is offering a lifeline to logistics companies which are under pressure to maintain a safe working environment and minimise disruption to operations.
Created by Delfin Health and DocHQ, Klaritycan help them remain operational by predicting, monitoring and testing the health and safety of their diverse workforce. It can give them a real-time clinical understanding of the health of all staff working across multimodal transportation, freight forwarding, warehousing and inventory management.
If logistics companies are to stay open, they need to be able to monitor the health and safety of their workforce in the most efficient way,” says Will Cooper, Founder and CEO at Delfin Health. “They need to follow safety protocols such as social distancing, forming bubbles, increasing cleaning and limiting the handling of goods to others. Introducing daily symptom checking and risk assessment is also critical, especially as logistics workers visit high risk places. This is where assessment tools like Klarity can help.”
The comprehensive solution will enable logistics companies to address their employees’ anxieties associated with returning to a safe work environment and about the future. It offers health risk assessments using explainable AI to determine the severity of Covid-19 for each employee. It also offers accurate and ongoing testing to assess their Covid-19 status, and continuous surveillance and symptom checking to inform and reassure employees.
The various testing methodologies, which include group and randomised testing, allow employers to reduce the amount of testing required and minimise the risk of an outbreak in the currently active workforce, in particular by identifying asymptomatic cases which are thought to play a significant role in the transmission of the disease.
The testing process, based on World Health Organisation (WHO) protocols, is guided by healthcare professionals who oversee and validate the results and use accredited tests including Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Saliva (MHRA approved) and Rapid RT-LAMP and, where relevant, rapid antibody tests. Further follow-up consultations can be provided as required.
Will adds: “It’s not enough for employers to simply rely on people using the test and trace government solution which tests only symptomatic people. With logistics facilities typically involving close contact, and vehicles often involving travelling passengers, a systematic process of regular testing is required. While regular testing might appear to be cost prohibitive, logistics companies using our technology can reduce costs by between 50-75% while also limiting the risk of asymptomatic spread of the virus.”